Olympus (OTCMKTS:OCPNY – Get Free Report) is one of 514 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare Olympus to related companies based on the strength of its risk, earnings, profitability, analyst recommendations, institutional ownership, dividends and valuation.
Profitability
This table compares Olympus and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Olympus | 13.80% | 24.30% | 9.30% |
| Olympus Competitors | -278.37% | -150.26% | -22.09% |
Volatility & Risk
Olympus has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Olympus’ competitors have a beta of 2.53, indicating that their average stock price is 153% more volatile than the S&P 500.
Insider and Institutional Ownership
Valuation and Earnings
This table compares Olympus and its competitors gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Olympus | $7.74 billion | $1.03 billion | 21.95 |
| Olympus Competitors | $1.88 billion | $144.09 million | 8.56 |
Olympus has higher revenue and earnings than its competitors. Olympus is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Analyst Recommendations
This is a summary of current ratings for Olympus and its competitors, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Olympus | 0 | 0 | 1 | 0 | 3.00 |
| Olympus Competitors | 4233 | 10323 | 17968 | 798 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 33.91%. Given Olympus’ competitors higher possible upside, analysts clearly believe Olympus has less favorable growth aspects than its competitors.
Dividends
Olympus pays an annual dividend of $0.08 per share and has a dividend yield of 0.4%. Olympus pays out 9.8% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.4% and pay out 44.6% of their earnings in the form of a dividend.
Summary
Olympus beats its competitors on 9 of the 15 factors compared.
Olympus Company Profile
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
